### COMPARISON OF DEEP-LEARNING BASED RECURRENCE FREE SURVIVAL WITH RANDOM SURVIVAL FOREST AND COX PROPORTIONAL HAZARD MODELS IN STAGE-I NSCLC PATIENTS
The curative treatment for stage I non-small cell lung cancer (NSCLC) is surgical resection. Even for stage I patients, the probability of recurrence after curative treatment is around 20%. In this repo, we are sharing the revised sample codes of DeepSurv library. For the original codes https://github.com/jaredleekatzman/DeepSurv.

For questions and concerns: iremkar.biostat@gmail.com
